openPR Logo
Press release

Point of Care Testing Market Industry Analysis With Abaxis, Inc., Kalila Medical (Abbott Laboratories), ACON Laboratories, Alere Inc., bioLytical Laboratories, Bio-Rad Laboratories, Danaher Corporation

03-04-2019 12:00 AM CET | Health & Medicine

Press release from: Global Market Insights, Inc

U.S. point of care testing market, by product, 2017 & 2024 (USD Million)

U.S. point of care testing market, by product, 2017 & 2024 (USD Million)

Increase in number of people suffering from infectious diseases and chronic conditions in developing nations such as China and India will boost the demand and adoption rate of point of care molecular diagnostic services. According to the statistics published by a UK-based organization, Avert, there were around 88,000 new incidence and nearly 69,000 deaths due to HIV infection in India in the year 2017. Hence, growing prevalence and awareness of infectious diseases will stimulate the growth of point of care testing devices market in the future.

Recent technological advancements in point of care testing devices will spur the industry growth in the forthcoming years. Use of several different combinations such as bio-sensing platforms with smartphone-integrated electronic readers will provide precise on-site and on-time diagnostics. With healthcare systems focusing more on population health, precision medicine and management of chronic disease, impact of point of care testing continues to grow, and several prominent point of care diagnostic trends have emerged in the last decade, augmenting the market growth.

Request for a sample of this research report @ https://www.gminsights.com/request-sample/detail/3086

High cost of the point of care testing devices will be one of the major factors responsible for impeding market growth in the upcoming years. The cost of individual point of care tests are mostly higher than the tests performed on large platforms. Hence, high cost of the testing devices will result in decline in device adoption, thereby restraining the market growth.

Glucose monitoring devices market held the majority of market share in the year 2017 and was valued around USD 5,308.2 million. Growing prevalence of diabetes in developed as well as developing nations will be the major driving factor for segmental growth. According to the International Diabetes Federation (IDF) and Diabetes Atlas, more than 415 million people, aged between 20-79 years, had diabetes in 2015 and this number is estimated to reach to 642 million by 2040. Change in lifestyle, dietary habits, increased smoking and alcohol consumption and other environmental factors are likely to upsurge this number, fueling the business growth in the forthcoming years.

Tumor/cancer marker testing products market is estimated to grow at 7.6% in the foreseeable future. Increase in prevalence of cancer across the globe will spur the demand and adoption rate of cancer or tumor marker testing products, boosting the business growth. According to the statistics published the by American Cancer Society, there were estimated 1.7 million new cancer cases diagnosed and 600,000 cancer deaths in the Unites States in 2018. Hence, growing number of people suffering from cancer will drive the growth of cancer marker testing products market in the forthcoming years.

Browse Full Report Details @ https://www.gminsights.com/industry-analysis/point-of-care-testing-market

Company profiled in this report based on Business overview, Financial data, Product landscape, Strategic outlook & SWOT analysis:

 Abaxis, Inc.
 Kalila Medical (Abbott Laboratories)
 ACON Laboratories
 Alere Inc.
 bioLytical Laboratories
 Bio-Rad Laboratories
 Danaher Corporation

Increase in number of people suffering from infectious diseases and chronic conditions in developing
Biosensors technology market was valued around USD 6,404.2 million in the year 2017 and is estimated to grow considerable rate over the forecast period. Rapid technological advancements, increasing acceptance of point of care diagnostics, increased applications of biosensors in the field of medical science and rising diabetic population base will drive the segmental growth during the forecast period. Role of biosensors in drug discovery and drug development has influenced the market growth positively.

Microfluidics technology market is projected to grow at a robust CAGR of 9.3% over the forecast period. The integration of advanced biosensor technologies and microfluidics is projected to result in improved point of care diagnostics over the coming years. Microfluidics-based point of care devices have the potential to provide enhanced patient care such as early detection and easy monitoring of diseases, and escalated personalization. Microfluidics-based point of care devices are largely used for studying cell growth and analysis in molecular biology reactions. Hence, growing applications of microfluidics technology will spur the business growth.

OTC testing market held market share of over 55% and was valued at USD 12,403.4 million in the year 2017. Robust growth of home healthcare sector coupled with growing demand and adoption of self-tests especially in case of blood glucose monitoring will drive the segment growth over the forecast period. OTC tests are cost-effective as well as easy operative in nature, leading to high growth rate.

Prescription-based testing market is estimated to grow lucratively at 7.5% during the projection period. Point of care testing in primary care enhances rational antibiotic prescribing, thereby stimulating its demand. Nearly 50% of antibiotic use in human medication is either inappropriate or unnecessary across all medical settings. To reduce this, there has been increased usage of prescription-based testing, hence propelling the market growth.

The application of point of care testing devices in blood glucose testing held the majority of market share and was valued at around USD 8,909.7 million in the year 2017. Diabetes prevalence is increasing in all parts of the world and most noticeably in upper and lower middle-income countries. The global prevalence of diabetes has increased two-fold since 1980. As per the WHO, around 422 million people were living with diabetes as of 2014 across the globe and half of them are still undiagnosed. Hence, increase in number of people suffering from diabetes will result in growing use and application of blood glucose testing products.

The application of point of care devices in infectious disease testing is projected to grow at 7.4% over the forecast timeframe. Growing incidence of infectious diseases globally will act as the primary driver for segmental growth. As per the CDC 2016 data, around 16.8 million people in the U.S. visit physician offices for parasitic and infectious diseases. Development of molecular diagnostics has enabled ease of use, speed and low cost for point of care applications. Hence, recent technological advancements and growing prevalence of infectious diseases will be responsible for the growth of point of care devices in the forthcoming future.

Use of point of care testing devices in hospitals was high in the year 2017 and amounted up to USD 7,543.4 million. Geriatric population suffering from chronic conditions such as cancer, HIV infection and diabetes require continuous monitoring and prefer minimally invasive procedures carried out in hospitals and clinics. Hospitals have high adoption rates for technologically advanced biopsy, mammography and other devices that are utilized in the treatment of cancer, therefore positively impacting the segmental growth.

Use of point of care testing devices in diagnostic centers is estimated to grow at a CAGR of 7.2% during the projection period. According to the Journal Clinical Diagnostic Laboratories, around 7 billion diagnostic tests are performed every year in the Unites States. Growing diagnostic tests have been a major factor driving the business growth. Moreover, increasing cases of chronic conditions such as obesity, cardiovascular diseases and cancer globally will upsurge the demand for diagnostic laboratories.

U.S. dominated the North America point of care testing market in the year 2017 and was valued around USD 8,738.3 million. Increasing prevalence of infectious diseases and growing application of POC tests for safe and early diagnosis will reinforces the regional dominance. Existence of a technologically advanced medical framework and recent technological advancements across the country will drive the point of care testing devices business growth in the country.

Make an inquiry for purchasing this report @ https://www.gminsights.com/inquiry-before-buying/3086

India point of care testing market is estimated to witness significant growth at a CAGR of 9.2% during the projection period. Growing per capita healthcare expenditure and rise in demand for rapid and cost effective in-vitro diagnostic devices will fuel point of care testing devices market growth. Also, growing awareness about early disease diagnosis and prevention will drive market growth in the region.

Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider; offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy and biotechnology.

Arun Hegde
Corporate Sales, USA
Global Market Insights, Inc.
Phone: 1-302-846-7766
Toll Free: 1-888-689-0688
Email: sales@gminsights.com
Web: https://www.gminsights.com
Blog: http://solutionrocket.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Point of Care Testing Market Industry Analysis With Abaxis, Inc., Kalila Medical (Abbott Laboratories), ACON Laboratories, Alere Inc., bioLytical Laboratories, Bio-Rad Laboratories, Danaher Corporation here

News-ID: 1628024 • Views: 795

More Releases from Global Market Insights, Inc

Refractories Market 2020 by top key players Saint-Gobain, Morgan Advanced Materi …
Global Refractories Market size was estimated at USD 30 billion in 2018 and is projected to surpass USD 41 billion by the year 2025. Refractories market is classified into monolithic, brick & shapes and others. Other refractories products is expected to gain close to 3% by 2025. Other refractory products include ceramic fibers and refractories raw materials used for manufacturing refractories inhouse. Ceramic fibers are lightweight, has high temperature stability and
Offshore Crane Market Trends 2020 By Industry Players Liebherr Group, National O …
The size of the overall Offshore Crane Market was recorded at USD 2.5 billion in the year 2018 and is now projected to surpass around USD 5 billion by 2026. The ongoing exploration of new offshore oil & gas fields will surge the demand for offshore cranes. The growing demand for maintenance & repair of oil & gas extraction systems will drive the offshore crane market growth. The equipment is primarily
Assisted Reproductive Technology Market Top Players | Cooper Surgical Inc., Cook …
Assisted Reproductive Technology Market will reach over USD 32.5 billion by 2024; as per a new research report. Increasing number of people suffering from infertility issues coupled with rising awareness about assisted reproductive technology (ART) will drive ART market over the forecast timeframe. Furthermore, changing social factors and rising disposable income should positively impact industry expansion. Procedures such as in-vitro fertilization are offered at low cost in developing countries such as
What's driving the Lithopone Market growth? | Leading Key Players Titanos, Langf …
A report by DecResearch estimates that the lithopone market size will be valued at over $235 million by 2025. Rapid global urbanization has given rise to a thriving construction industry which is a significant contributor to the lithopone market growth. The strong reducing power and chemically inert nature of lithopone has led to its extensive application across numerous industries including paints & coatings, paper& pulp, rubber, leather, plastics and linoleum

All 5 Releases


More Releases for USD

$100,000,000 USD job contract for travel - $3,000,000 USD referral commission.
Khoja Consultants invites applications for companies, teams or venture capitalists for a $100,000,000 USD job contract for travel. The selected company will be providing all accommodations and expenses for a 6-month long business trip around the world. Khoja Consultants expects five-star treatment including close security with private planes, hotels, secured vehicles and helicopters if necessary. More details on the job contract and application are provided at - www.KhojaConsultants.com. There
Polyurethane Dispersions Market worth USD 2.04 Billion USD by 2020
The report " Polyurethane Dispersions Market by Type (Water-Based Polyurethane Dispersions and Solvent-Based Polyurethane Dispersions), by Application (Coatings, Adhesives & Sealants, Synthetic Leather Production, Fiber Glass Sizing, and Others) - Trends & Forecasts to 2020", The global polyurethane dispersions market is projected to reach USD 2.04 Billion by 2020 at a CAGR of 6.8% between 2015 and 2020. This growth is fueled by the high potential from the textile and
Retail Analytics Market worth USD 5.1 Billion USD by 2020
According to a new market research report "Retail Analytics Market by Business Function (Marketing and Customer Analytics, Merchandizing and In-Store Analytics, Supply Chain Analytics, Strategy and Planning), by Type, by Solutions and by Services - Global Forecast and Analysis to 2020", defines and segments the global retail analytics market on the basis of business function, solutions, services, deployment types, and regions along with providing an in-depth analysis and market size
Metabolomics Market USD 1.24 Billion by 2020
The global metabolomics market is estimated to reach USD 1.24 Billion in 2020, growing at a CAGR of 15.6% from 2016 to 2020, according to a market research report Metabolomics Market 2013-2020, published by iHealthcareAnalyst, Inc. Visit the Metabolomics Market 2013-2020 report at https://www.ihealthcareanalyst.com/report/metabolomics-market/ Metabolomics is the scientific study of chemical processes involving metabolites, whereas metabolome represents the collection of all metabolites in a biological cell, tissue, organ or organism, which
Radiopharmaceuticals Market USD 350 Million by 2020
Radiopharmaceuticals Market 2013-2020 report estimates the global radiopharmaceuticals market to reach nearly USD 350 Million in 2020, at a CAGR of 4.9% from 2016 to 2020 - iHealthcareAnalyst, Inc. Visit the Radiopharmaceuticals Market 2013-2020 report https://www.ihealthcareanalyst.com/report/radiopharmaceuticals-market/ Medicinal radiocompounds or radiopharmaceuticals are a group of pharmaceutical drugs which have radioactivity and they can be used as diagnostic and therapeutic agents. Radiopharmaceuticals are used in the field of nuclear medicine as radioactive tracers
Orthobiologics Market USD 5.8 Billion by 2020
Orthobiologics Market 2013-2020 report estimates the global orthobiologics market to reach nearly USD 5.8 Billion in 2020, at a CAGR of 6.2% from 2016 to 2020 - iHealthcareAnalyst, Inc. Visit the Orthobiologics Market 2013-2020 report https://www.ihealthcareanalyst.com/report/orthobiologics-market/ The global orthobiologics market report provides market size (Revenue USD Million 2013 to 2020), market share and forecasts growth trends (CAGR%, 2016 to 2020). The global orthobiologics market segmentation is based on product types (allograft, bone